PerkinElmer Appoints Karl Hecker to Head Key R&D Center
News Jan 19, 2006
PerkinElmer, Inc. has announced appointment of Dr. Karl Hecker as Director of Research & Development for its Boston-based Center of Excellence.
He will lead all product R&D efforts for the Center, which focuses on molecular medicine solutions for the company's Life and Analytical Sciences unit.
These solutions include chemistries, reagents, instruments and software serving the needs of customers engaged in areas such as proteomics, genomics and life sciences research.
Dr. Hecker joins PerkinElmer from Invitrogen and brings over 20 years of scientific experience in chemistry and biochemistry applications.
"Karl is a talented scientist and an innovative leader, and we are delighted to have him join our R&D team," said Robert F. Friel, Vice Chairman, PerkinElmer Inc.
"We are committed to adding strong domain knowledge to support our growth in the burgeoning areas of molecular medicine and this is an important step forward."
Dr. Hecker holds a Ph.D. in biochemistry from Florida State University, a master's of science degree in chemistry from Eastern Illinois University, and master's and bachelor of science degrees in chemistry from Johann Wolfgang, Goethe University, Frankfurt Germany.
Using EBX reagents, researchers have converted the C-terminal carboxylic acid of peptides into a carbon-carbon triple bond - an alkyne (in chemical jargon a "decarboxylative alkynylation"). The alkyne moiety is a very valuable functional group that can be used to further modify the peptides.READ MORE